Jan Eickhoff

3.0k total citations · 1 hit paper
38 papers, 1.8k citations indexed

About

Jan Eickhoff is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Jan Eickhoff has authored 38 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Epidemiology and 12 papers in Oncology. Recurrent topics in Jan Eickhoff's work include Cytomegalovirus and herpesvirus research (12 papers), Cancer-related Molecular Pathways (6 papers) and Herpesvirus Infections and Treatments (6 papers). Jan Eickhoff is often cited by papers focused on Cytomegalovirus and herpesvirus research (12 papers), Cancer-related Molecular Pathways (6 papers) and Herpesvirus Infections and Treatments (6 papers). Jan Eickhoff collaborates with scholars based in Germany, Norway and United States. Jan Eickhoff's co-authors include Bert Klebl, Peter Habenberger, Axel Choidas, Sascha Menninger, Raffaella Di Lucrezia, Renate Krüger, Gabriel Sollberger, Garth L. Burn, Peter Nußbaumer and Arturo Zychlinsky and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Molecular and Cellular Biology.

In The Last Decade

Jan Eickhoff

37 papers receiving 1.8k citations

Hit Papers

Gasdermin D plays a vital... 2018 2026 2020 2023 2018 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jan Eickhoff 1.1k 541 293 260 147 38 1.8k
Ryusho Kariya 594 0.5× 347 0.6× 132 0.5× 453 1.7× 84 0.6× 72 1.5k
Peter Teriete 1.0k 0.9× 303 0.6× 536 1.8× 267 1.0× 83 0.6× 44 1.9k
Katerina V. Gurova 2.3k 2.0× 292 0.5× 205 0.7× 823 3.2× 207 1.4× 84 3.1k
Peter Habenberger 846 0.7× 472 0.9× 153 0.5× 118 0.5× 86 0.6× 17 1.3k
Sara J. Buhrlage 1.9k 1.7× 429 0.8× 265 0.9× 717 2.8× 108 0.7× 66 2.9k
Dorothy Hudig 1.1k 0.9× 1.1k 2.0× 213 0.7× 518 2.0× 61 0.4× 79 2.4k
Laura M. Bartle 892 0.8× 544 1.0× 845 2.9× 530 2.0× 47 0.3× 27 2.2k
James Greger 895 0.8× 261 0.5× 134 0.5× 615 2.4× 144 1.0× 28 1.5k
Srinivas K. Chunduru 1.6k 1.4× 640 1.2× 337 1.2× 434 1.7× 45 0.3× 42 2.3k
Jeffrey A. Heibein 983 0.9× 711 1.3× 270 0.9× 275 1.1× 48 0.3× 11 1.7k

Countries citing papers authored by Jan Eickhoff

Since Specialization
Citations

This map shows the geographic impact of Jan Eickhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Eickhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Eickhoff more than expected).

Fields of papers citing papers by Jan Eickhoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Eickhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Eickhoff. The network helps show where Jan Eickhoff may publish in the future.

Co-authorship network of co-authors of Jan Eickhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Eickhoff. A scholar is included among the top collaborators of Jan Eickhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Eickhoff. Jan Eickhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wagner, Sabrina, Martin Schütz, Jaeseung Kim, et al.. (2024). An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity. Pharmaceutics. 16(2). 158–158. 6 indexed citations
3.
Tillmanns, Julia, Eva Maria Borst, Jan Eickhoff, et al.. (2023). Assessment of Covalently Binding Warhead Compounds in the Validation of the Cytomegalovirus Nuclear Egress Complex as an Antiviral Target. Cells. 12(8). 1162–1162. 8 indexed citations
4.
Eickhoff, Jan, Sabrina Wagner, William C. Chang, et al.. (2023). Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers. Pharmaceutics. 15(12). 2680–2680. 8 indexed citations
5.
Rückert, Christian, Tobias Busche, Alexander Wolf, et al.. (2023). Characterization of the Antibacterial Activity of Quinone-Based Compounds Originating from the Alnumycin Biosynthetic Gene Cluster of a Streptomyces Isolate. Antibiotics. 12(7). 1116–1116. 3 indexed citations
6.
Andrei, Sebastian A., Yusuke Higuchi, Nobuo Kato, et al.. (2023). IFNα primes cancer cells for Fusicoccin-induced cell death via 14-3-3 PPI stabilization. Cell chemical biology. 30(6). 573–590.e6. 12 indexed citations
7.
Eickhoff, Jan, Bert Klebl, Anke Unger, et al.. (2023). A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiation. European Journal of Medicinal Chemistry. 255. 115344–115344. 7 indexed citations
8.
Schütz, Martin, Christina Wangen, Melanie Kögler, et al.. (2023). Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiency. Virus Research. 335. 199200–199200. 8 indexed citations
9.
Seyler, Lisa, Christina Wangen, Luca D. Bertzbach, et al.. (2021). Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs). International Journal of Molecular Sciences. 22(2). 575–575. 27 indexed citations
10.
Andersen, Jeanette H., Annette Bayer, Kåre B. Jørgensen, et al.. (2019). Kinase Chemodiversity from the Arctic: The Breitfussins. Journal of Medicinal Chemistry. 62(22). 10167–10181. 25 indexed citations
11.
Sonntag, Eric, Friedrich Hahn, Luca D. Bertzbach, et al.. (2018). In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus model. Antiviral Research. 161. 63–69. 27 indexed citations
12.
Sollberger, Gabriel, Axel Choidas, Garth L. Burn, et al.. (2018). Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Science Immunology. 3(26). 571 indexed citations breakdown →
13.
Stevers, Loes M., Eline Sijbesma, Maurizio Botta, et al.. (2017). Modulators of 14-3-3 Protein–Protein Interactions. Journal of Medicinal Chemistry. 61(9). 3755–3778. 210 indexed citations
14.
Chakedis, Jeffery, Randall P. French, Michele Babicky, et al.. (2016). Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics. Oncotarget. 7(29). 45959–45975. 24 indexed citations
15.
Jacquet, Sébastien, Yasuhiro Nishino, Sarawut Kumphune, et al.. (2008). The Role of RIP2 in p38 MAPK Activation in the Stressed Heart. Journal of Biological Chemistry. 283(18). 11964–11971. 33 indexed citations
16.
Schleiss, Mark R., Jan Eickhoff, Sabrina Auerochs, et al.. (2008). Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo. Antiviral Research. 79(1). 49–61. 73 indexed citations
17.
Godl, Klaus, Oliver J. Gruß, Jan Eickhoff, et al.. (2005). Proteomic Characterization of the Angiogenesis Inhibitor SU6668 Reveals Multiple Impacts on Cellular Kinase Signaling. Cancer Research. 65(15). 6919–6926. 84 indexed citations
18.
Eickhoff, Jan, Matthias Stein-Gerlach, Peter Habenberger, et al.. (2004). RICK Activates a NF-κB-dependent Anti-human Cytomegalovirus Response. Journal of Biological Chemistry. 279(10). 9642–9652. 31 indexed citations
19.
Buschbeck, Marcus, et al.. (2002). Phosphotyrosine-specific Phosphatase PTP-SL Regulates the ERK5 Signaling Pathway. Journal of Biological Chemistry. 277(33). 29503–29509. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026